| Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease |
| S Hellman |
|
JCO Oct 1 1985: 1293.
[PDF]
|
 |
| Chemotherapy in seminoma: when is it appropriate initial treatment? |
| JR Daniels |
|
JCO Oct 1 1985: 1294–1295.
[PDF]
|
|
|
Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease |
| |
RE Lenhard, Jr, SE Order, JJ Spunberg, SO Asbell, and SA Leibel |
| |
JCO Oct 1 1985: 1296–1300.
[Abstract]
[PDF]
|
|
|
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas |
| |
P Mauch, R Leonard, A Skarin, D Rosenthal, S Come, J Chaffey, S Hellman, and G Canellos |
| |
JCO Oct 1 1985: 1301–1308.
[Abstract]
[PDF]
|
|
|
Long-term survival of patients with localized diffuse histiocytic lymphoma |
| |
EE Vokes, JE Ultmann, HM Golomb, ER Gaynor, DJ Ferguson, ML Griem, and D Oleske |
| |
JCO Oct 1 1985: 1309–1317.
[Abstract]
[PDF]
|
|
|
Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study |
| |
SE Jones, PN Grozea, TP Miller, EJ Van Slyck, SP Balcerzak, JJ Costanzi, FS Morrison, HJ Eyre, CJ Fabian, and L Dabich |
| |
JCO Oct 1 1985: 1318–1324.
[Abstract]
[PDF]
|
|
|
Therapeutic guidelines and results in advanced seminoma |
| |
EL Friedman, MB Garnick, PC Stomper, PM Mauch, DP Harrington, and JP Richie |
| |
JCO Oct 1 1985: 1325–1332.
[Abstract]
[PDF]
|
|
|
Radiotherapy as initial treatment for bulky stage II testicular seminomas |
| |
SR Smalley, RG Evans, RL Richardson, GM Farrow, and JD Earle |
| |
JCO Oct 1 1985: 1333–1338.
[Abstract]
[PDF]
|
|
|
Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation |
| |
A Recht, BS Danoff, LJ Solin, S Schnitt, J Connolly, L Botnick, I Goldberg, RL Goodman, and JR Harris |
| |
JCO Oct 1 1985: 1339–1343.
[Abstract]
[PDF]
|
|
|
The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas |
| |
AE Giuliano and FR Eilber |
| |
JCO Oct 1 1985: 1344–1348.
[Abstract]
[PDF]
|
|
|
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer |
| |
JP Sculier, R Feld, WK Evans, FA Shepherd, G DeBoer, DG Malkin, and A Malkin |
| |
JCO Oct 1 1985: 1349–1354.
[Abstract]
[PDF]
|
|
|
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma |
| |
H Sekine, DF Hayes, T Ohno, KA Keefe, E Schaetzl, RC Bast, R Knapp, and DW Kufe |
| |
JCO Oct 1 1985: 1355–1363.
[Abstract]
[PDF]
|
|
|
Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer |
| |
AG Pedersen, FW Bach, M Nissen, and F Bach |
| |
JCO Oct 1 1985: 1364–1372.
[Abstract]
[PDF]
|
|
|
High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity |
| |
SS Legha and IW Dimery |
| |
JCO Oct 1 1985: 1373–1378.
[Abstract]
[PDF]
|
|
|
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin |
| |
MG Kris, RJ Gralla, RA Clark, LB Tyson, JP O'Connell, MS Wertheim, and DP Kelsen |
| |
JCO Oct 1 1985: 1379–1384.
[Abstract]
[PDF]
|
|
|
Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion |
| |
S Leyvraz, T Ohnuma, M Lassus, and JF Holland |
| |
JCO Oct 1 1985: 1385–1392.
[Abstract]
[PDF]
|
|
|
Psychological outcome of extremity sarcoma survivors undergoing amputation or limb salvage |
| |
WW Weddington, Jr, KB Segraves, and MA Simon |
| |
JCO Oct 1 1985: 1393–1399.
[Abstract]
[PDF]
|
|
|
Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy |
| |
JE McDermed, JL Cohen, C Joseph, and SB Strum |
| |
JCO Oct 1 1985: 1400–1408.
[Abstract]
[PDF]
|
|
|
Improvements in data collection through physician use of a computer- based chemotherapy treatment consultant |
| |
DL Kent, EH Shortliffe, RW Carlson, MB Bischoff, and CD Jacobs |
| |
JCO Oct 1 1985: 1409–1417.
[Abstract]
[PDF]
|
|
|
Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer |
| |
RJ Simes and M Zelen |
| |
JCO Oct 1 1985: 1418–1431.
[Abstract]
[PDF]
|
|
| Ethics in oncology textbooks |
| GB Weiss and HY Vanderpool |
|
JCO Oct 1 1985: 1432–1436.
[PDF]
|
|
| AIDS in association with malignant melanoma and Hodgkin's disease |
| GE Moore and DD Cook |
|
JCO Oct 1 1985: 1437a.
[PDF]
|
|
| Vincristine infusion with advanced, relapsed tumors |
| R Pinkerton, T Philip, P Biron, and MB Mentigny |
|
JCO Oct 1 1985: 1437b–1438.
[PDF]
|
|
| Utility of non-invasive instantaneous screening test for drug-induced cardiac damage |
| WJ Hrushesky |
|
JCO Oct 1 1985: 1438–1439.
[PDF]
|
|
